Jhansi Lakshmi Gajjala

Jhansi Gajjala practices at Howard University in Washington, District of Columbia.

Jhansi Gajjala's NPI, 1548437106, was assigned on May 13, 2008. Jhansi Gajjala holds District of Columbia license MD036368.

Jhansi Gajjala's primary practice is Howard University, at 2139 Georgia NW Ave, Washington, DC 20001 in District Of Columbia County. The practice phone is (202) 595-3223.

Jhansi Gajjala's primary practice is Howard University in Washington, District of Columbia. Jhansi Gajjala is also affiliated with Howard University Hospital. The medical group on file is Howard University Faculty Practice Plan. Dmand AI also links Jhansi Gajjala to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jhansi Gajjala practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Jhansi Gajjala's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Jhansi Gajjala is licensed in District of Columbia.

CMS data shows 256 Medicare services from Jhansi Gajjala across 2 procedure codes in 2024, for 104 Medicare patients. Medicare paid $20,153 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Jhansi Gajjala in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jhansi Gajjala's median patient age at 57, with 43% women.

In 2024, Jhansi Gajjala wrote 192 Medicare Part D claims for 30 patients. 17% of them were for generic drugs. CMS names the drug for 132 of them, across 5 drugs with 11 or more claims each, at $469,044 in total drug cost. In 2023, CMS named 45 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Jhansi Gajjala for performance year 2024, reported as part of a group. Jhansi Gajjala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Jhansi Gajjala, published from 2011 to 2023. 2016 was the busiest year, with 2. The most frequent topics are District of Columbia. Jhansi Gajjala has published most often in Cureus. Jhansi Gajjala's most frequent co-authors are Sohail Ahmed, MD, Ikechukwu Elvis Eze, MD and Mona A. Kaleem, MD.

CMS Open Payments shows 14 general payments to Jhansi Gajjala from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Janssen Pharmaceuticals, Inc paid the most, $368.